Xeno-free extraction, culture, and cryopreservation of human adipose-derived mesenchymal stem cells
Molecules of animal or bacterial origin, which pose a risk for zoonoses or immune rejection, are com-monly used for extraction, culture, and cryopreservation of mesenchymal stem cells. There is no se-quentialandorderlyprotocolforproducinghumanadipose-derivedstemcells(hASCs)underxeno-freeconditions....
- Autores:
-
Escobar, Carlos Hugo
Chaparro, Orlando
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2016
- Institución:
- Fundación Universitaria de Ciencias de la Salud - FUCS
- Repositorio:
- Repositorio Digital Institucional ReDi
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.fucsalud.edu.co:001/2699
- Acceso en línea:
- https://repositorio.fucsalud.edu.co/handle/001/2699
- Palabra clave:
- Adipose
Adult stem cells
Xeno-free production
Human platelet lysate
Explant culture
Cryopreservation
Criopreservación
Tejido
Antígenos de plaqueta humana
Adipocitos
Células madre adultas
Anticuerpos heterófilos
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
Summary: | Molecules of animal or bacterial origin, which pose a risk for zoonoses or immune rejection, are com-monly used for extraction, culture, and cryopreservation of mesenchymal stem cells. There is no se-quentialandorderlyprotocolforproducinghumanadipose-derivedstemcells(hASCs)underxeno-freeconditions. Afterstandardizinga humanplateletlysate (hPL) productionprotocol,four humanadiposetissue samples were processed through explants with fetal bovine serum (FBS)-supplemented or hPL-supplemented media for extracting the adipose-derived stem cells. The cells were cultivated in cellculture medium + hPL (5%) or FBS (10%). The cellular replication rate, immunophenotype, and differ-entiation potential were evaluated at fourth passage. Cellular viability was evaluated before and aftercryopreservation of the cells, with an hPL-based solution compared with an FBS-based solution. Theexplants cultured in hPL-supplemented media showed earlier and faster hASC proliferation than didthosesupplementedwithFBS.Likewise,cellsgrowninhPL-supplementedmediashowedagreaterpro-liferation rate, without losing the immunophenotype. Osteogenic differentiation of xeno-free hASCwas higher than the hASC produced in standard conditions. However, adipogenic differentiationwas reduced in xeno-free hASC. Finally, the cells cryopreserved in an hPL-based solution showed ahigher cellular viability thanthecells cryopreserved inanFBS-based.In conclusion, we have developeda complete xeno-free protocol for extracting, culturing, and cryopreserving hASCs that can be safelyimplemented in clinical studies. |
---|